Top Markets
Coin of the day
ZIVO Bioscience, Inc. ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc.

ZIVOW
Rank in Stocks #40373
ZIVO Bioscience, Inc. is a research and development firm specializing in the... ZIVO Bioscience, Inc. is a research and development firm specializing in the creation, licensing, and distribution of natural bioactive compounds. These ingredients, derived from its exclusive algal strains, are supplied to manufacturers across the animal health, human health, dietary supplement, and medical food sectors. Active across the biotechnology and agricultural technology domains, ZIVO possesses a comprehensive intellectual property estate. This encompasses unique algal and bacterial strains, novel biologically active molecules and complexes, specialized production and cultivation methodologies, and a suite of patented or patent-pending innovations designed for both human and animal health solutions. The company's offerings address a diverse range of health concerns, such as promoting gut health in poultry, combating bovine mastitis, enhancing joint function in canines, modulating human immune responses, providing algal biomass for direct human consumption, and supporting skin vitality and anti-aging efforts. Previously operating as Health Enhancement Products, Inc., the firm adopted the ZIVO Bioscience, Inc. name in October 2014. Its corporate headquarters are situated in Bloomfield Hills, Michigan.
Share Price
$0.044
Last synced: 2025-12-26
Market Cap
$164.23K
Change (1 day)
-92.00%
Change (1 year)
-92.00%
Country
US
Trade ZIVO Bioscience, Inc. (ZIVOW)

Category

Revenue for ZIVO Bioscience, Inc. (ZIVOW)
Revenue in Aug 2026 TTM: 0
According to ZIVO Bioscience, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ZIVO Bioscience, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE